biote Corp.
BTMD
$1.47
-$0.02-1.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 183.53M | 188.16M | 192.22M | 195.65M | 199.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 183.53M | 188.16M | 192.22M | 195.65M | 199.07M |
| Cost of Revenue | 57.07M | 56.23M | 54.86M | 54.06M | 55.80M |
| Gross Profit | 126.46M | 131.93M | 137.36M | 141.58M | 143.27M |
| SG&A Expenses | 105.53M | 101.78M | 101.26M | 104.36M | 101.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 162.60M | 158.01M | 156.12M | 158.43M | 157.62M |
| Operating Income | 20.93M | 30.16M | 36.10M | 37.22M | 41.46M |
| Income Before Tax | 10.26M | 23.47M | 37.58M | 30.76M | 38.17M |
| Income Tax Expenses | 3.18M | 5.03M | 5.99M | -1.70M | 2.26M |
| Earnings from Continuing Operations | 7.08 | 18.43 | 31.60 | 32.46 | 35.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.23M | -2.83M | -4.55M | -3.67M | -4.60M |
| Net Income | 5.86M | 15.60M | 27.05M | 28.79M | 31.31M |
| EBIT | 20.93M | 30.16M | 36.10M | 37.22M | 41.46M |
| EBITDA | 23.77M | 32.75M | 38.57M | 39.68M | 43.67M |
| EPS Basic | 0.17 | 0.50 | 0.86 | 0.92 | 1.00 |
| Normalized Basic EPS | 0.21 | 0.33 | 0.37 | 0.44 | 0.47 |
| EPS Diluted | 0.11 | 0.44 | 0.75 | 0.79 | 0.90 |
| Normalized Diluted EPS | 0.19 | 0.31 | 0.34 | 0.40 | 0.43 |
| Average Basic Shares Outstanding | 121.30M | 124.30M | 125.14M | 125.73M | 125.44M |
| Average Diluted Shares Outstanding | 132.16M | 135.27M | 136.23M | 142.70M | 138.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.14% | 10.18% | 8.44% | 7.93% | 8.71% |